We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
featured
Published in Gastroenterology

Journal Scan / Research · February 18, 2023

The Performance of AFP, AFP-L3, and DCP as Biomarkers for the Detection of Hepatocellular Carcinoma

Clinical Gastroenterology and Hepatology

 

 Save  Recommend
 Share

Additional Info

Clinical Gastroenterology and Hepatology
The Performance of AFP, AFP-3, DCP as Biomarkers for Detection of Hepatocellular Carcinoma (HCC): A Phase 3 Biomarker Study in the United States
Clin. Gastroenterol. Hepatol. 2023 Feb 01;21(2)415-423.e4, N Tayob, F Kanwal, A Alsarraj, R Hernaez, HB El-Serag

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated